Bel­gian CD­MO of­fers new LNP ser­vice as de­mand for RNA-de­liv­ery ser­vices heats up

4 years ago
Pharma
Manufacturing

Sanofi R&D team ac­cel­er­ates block­buster de­vel­op­ment ef­forts — while cast­ing doubt on a heavy­weight ri­val’s plans

4 years ago
Bioregnum

Mar­ket­ingRx roundup: No­vo Nordisk Type 1 cy­cling team stars in doc­u­men­tary; GSK, Vi­a­tris, Vi­iV top in­no­va­tion list

4 years ago
Pharma
Marketing

Con­cer­tAI sings a uni­corn tune as the FDA-part­nered clin­i­cal tri­als soft­ware up­start ex­pands

4 years ago
Financing
AI

As shares sky­rock­et on Sanofi deal, IGM Bio­sciences looks to bag $200M

4 years ago
Financing

Ama­zon jumps in­to de­cen­tral­ized tri­als push as AWS part­ners with start­up to cut down on in­ef­fi­cien­cies

4 years ago
Deals

Antares Phar­ma wins FDA OK for oral testos­terone treat­ment; Eye-fo­cused biotech re­ports PhI­II da­ta for pupil di­la­tion ...

4 years ago
News Briefing

Tout­ing a wad of cash in the wake of a clin­i­cal im­plo­sion, a small biotech re­views some lim­it­ed op­tions

4 years ago
R&D

With Bris­tol My­ers in its sights, Pfiz­er de­clares it­self the win­ner in the S1P drug race to come — but you’ll ...

4 years ago
R&D

In a twist, cell ther­a­py de­vel­op­er sees C-suite ex­o­dus while slash­ing costs

4 years ago
People

Paul Hud­son spells out new $6.15B tech­nol­o­gy play as Sanofi goes drug hunt­ing in on­col­o­gy, im­munol­o­gy

4 years ago
Deals

In­side the race to make psy­che­delics 'main­stream med­i­ci­nes'

4 years ago
R&D
In Focus

Up­ping ex­pec­ta­tions, Sanofi makes its case on why Dupix­ent will go on to $14.5B in peak sales — what­ev­er Eli Lil­ly ...

4 years ago
Marketing

GSK and Med­ica­go have glob­al plans for their Covid-19 vac­cine. But WHO balks at Big To­bac­co in­vestor

4 years ago
Pharma

Eli Lil­ly ver­sus the 800-pound go­ril­la in atopic der­mati­tis? It may just have a shot — at 2nd place

4 years ago
R&D
Pharma

Roche’s Genen­tech re­news MS cam­paign aimed at ‘break­ing bar­ri­ers’ for un­der­rep­re­sent­ed pa­tients

4 years ago
Pharma
Marketing

Jazz plots mas­sive growth for UK cannabi­noid op­er­a­tions

4 years ago
Pharma
Manufacturing

In quick turn, ten23 al­ready look­ing to ex­pand Visp fill-fin­ish site

4 years ago
Pharma
Manufacturing

Once her­ald­ed as its next big cash cow, Jazz takes a marked down price for not-so-hot sleep dis­or­der drug

4 years ago
Deals
Pharma

Pfiz­er, No­var­tis and Eli Lil­ly among phar­mas hit­ting the red car­pet with Acad­e­my Award TV ads

4 years ago
Pharma
Marketing

Af­ter CRL, CorMedix says new fil­ing has been ac­cept­ed by FDA; Spine Bio­Phar­ma nets a mod­est Se­ries B

4 years ago
News Briefing

FDA calls for Hatch-Wax­man tweak, ac­cel­er­at­ed ap­proval re­forms in Pres­i­dent Biden's 2023 bud­get pro­pos­al

4 years ago
FDA+

Re­searchers point to a host-di­rect­ed Covid-19 an­tivi­ral that could be com­bined with ex­ist­ing pan­dem­ic treat­ments

4 years ago
R&D
Coronavirus

Slammed with fresh clin­i­cal fail­ure, Bio­gen and Io­n­is dis­card ear­ly-stage ALS can­di­date

4 years ago
R&D
First page Previous page 559560561562563564565 Next page Last page
A service from the Financial Times